[The cholesterol controversy (author's transl)].

H. Stähelin

Abstract:

What problem does this paper attempt to address?

Retrospective cohort study exploring the impact of universal Tuberculosis (TB) vaccination cessation on the epidemiology of paediatric TB in Ireland, 2011–2021

Sarah Jackson,Zubair Kabir,Catherine Comiskey

DOI: https://doi.org/10.1016/j.vaccine.2024.02.061

IF: 4.169

2024-02-01

Vaccine

Abstract:BACKGROUND: Since 2010, Ireland's Tuberculosis (TB) crude incidence rate (CIR) remains below 10 per 100,000 population defining it as a low TB incidence country. Ireland maintained a universal BCG vaccination programme until its discontinuation in 2015 due to lack of vaccine supply. This study explores the impact of discontinuing a national universal BCG vaccination programme on the epidemiology of paediatric TB cases.METHODS: We retrospectively analysed TB notifications aged 0-6 years old reported to the Irish National TB Surveillance System between 2011 and 2021. Key epidemiological characteristics and temporal trends in TB age specific incidence rates (ASIRs) were compared between 0 and 6 year old cases born during a period of universal BCG vaccination (2007-2015) and 0-6 year old cases born after BCG vaccination ceased (2015-2021).RESULTS: No significant temporal trend was detected in the overall 0-6 year old ASIR by notification year during 2011-2021 (IRR:0.95; 0.86-1.1). However, the temporal trend for cases born during universal vaccination showed a significant decline (0.74; CIR: 0.62-0.89) while cases born after BCG vaccination ceased had a non-significant increase (1.2; CIR: 0.73-1.86). A significantly declining temporal trend was detected among cases born in Ireland during universal vaccination (IRR:0.73; 0.62-0.86), but no significant trend was detected in the cases born outside Ireland during universal vaccination (IRR:0.83; 0.53-1.31). No significant trend was detected in cases born after vaccination ceased in either cases born in Ireland (IRR:1.0; 0.60-1.65) or those born outside Ireland (IRR:0.64; 0.29-1.40).CONCLUSIONS: Universal BCG cessation has not yet directly impacted on TB cases among 0-6 year olds in Ireland. However, interruption of the previously declining temporal trend in this cohort during universal vaccination may be an early warning of a future increase. Paediatric TB cases remain an important cohort for timely surveillance to monitor trends in this primarily unvaccinated cohort to evaluate the long-term effects.

immunology,medicine, research & experimental
Effectiveness of Bacillus Calmette–Guérin vaccination against severe childhood tuberculosis in China: a case-based, multicenter retrospective study

Qiong Liao,Yangming Zheng,Yanchun Wang,Leping Ye,Xiaomei Liu,Weiwei Jiao,Yang Liu,Yu Zhu,Jihang Jia,Lin Sun,Adong Shen,Chaomin Wan

DOI: https://doi.org/10.1016/j.ijid.2022.04.023

IF: 12.073

2022-04-01

International Journal of Infectious Diseases

Abstract:BACKGROUNDEvidence varies regarding the efficacy of Bacillus Calmette-Guérin (BCG) vaccine. Data on protection by BCG vaccination against severe tuberculosis (TB) among children in China remains unclear.METHODSWe conducted a case-based, multicenter retrospective study at three children's hospitals in China. Sociological factors affecting BCG vaccination and risk factors associated with diseases types were analyzed using a multivariable model.RESULTSA total 1701 children with active TB were enrolled. Children who were younger, female, resident in a rural area, living in the western regions, and with no BCG vaccination history were at higher risk of developing severe TB. Children with a BCG scar had significantly lower risk for severe TB (odds ratio (OR) 0.59, 95% confidence interval (CI) 0.51–0.67). Children with no BCG scar but who were vaccinated at birth still had lower risk of severe TB types, such as tuberculous meningitis (OR 0.88, 95% CI 0.80–0.97) and miliary TB (OR 0.77, 95% CI 0.69–0.87).CONCLUSIONSNeonatal BCG vaccination could be an effective means to control TB. In the absence of a new, more effective TB vaccine, our results lend support to continued use of the BCG vaccine in China.

infectious diseases
Diagnostic Accuracy of Clinical Diagnostic Scoring Systems for Childhood Tuberculosis: A Systematic Review and Meta-Analysis

Michael Kakinda,Ronald Olum,Joseph Baruch Baluku,Felix Bongomin

DOI: https://doi.org/10.1093/ofid/ofad624

2023-12-11

Open Forum Infectious Diseases

Abstract:Abstract Background Diagnosis of childhood tuberculosis (TB) poses several challenges. Therefore, point-based scoring systems and diagnostic algorithms have been developed to improve the diagnostic yields in this population. However, there are no updated systematic reviews of the existing childhood TB scoring systems and algorithms. Hence, we systematically reviewed the diagnostic accuracy of the childhood TB diagnostic scoring systems and algorithms. Methods We systematically searched PubMed, CINAHL, Embase, Scopus, and Google Scholar databases for relevant articles published until March 30, 2023. QUADAS-2 was used to assess their study quality. Diagnostic accuracy measures (i.e., sensitivity, specificity, diagnostic odds ratio [DOR], positive likelihood ratio [LR+], and negative likelihood ratio [LR]) were pooled using a random-effects model. All statistical analyses were performed using MetaDTA and STATA SE version 17. Results We included 15 eligible studies, with a total of 7,327 study participants aged less than 15 years, with 10 evaluations of childhood TB diagnostic scoring systems and algorithms. Among these algorithms and scoring systems, only three were evaluated more than once. These were Keith Edward’s scoring system with five studies (sensitivity-81.9% and specificity-81.2%), Kenneth Jones Criteria (sensitivity-80.1% and specificity-45.7%), and the MoH Brazil Algorithm (sensitivity: 79.9% and specificity-73.2%) with three studies each. Conclusion We recommend using the Keith Edwards scoring system because of its high sensitivity and specificity. Further research is necessary to assess the effectiveness of scoring systems and algorithms in identifying tuberculosis in children with HIV and malnutrition.

immunology,infectious diseases,microbiology
Pulmonary function outcomes after tuberculosis treatment in children: a systematic review and meta-analysis

Yao Long Lew,Angelica Fiona Tan,Stephanie T Yerkovich,Tsin Wen Yeo,Anne B Chang,Christopher P Lowbridge

DOI: https://doi.org/10.1136/archdischild-2023-326151

2024-02-19

Abstract:Background: Despite tuberculosis (TB) being a curable disease, current guidelines fail to account for the long-term outcomes of post-tuberculosis lung disease-a cause of global morbidity despite successful completion of effective treatment. Our systematic review aimed to synthesise the available evidence on the lung function outcomes of childhood pulmonary tuberculosis (PTB). Methods: PubMed, ISI Web of Science, Cochrane Library and ProQuest databases were searched for English-only studies without time restriction (latest search date 22 March 2023). Inclusion criteria were (1) patients who had TB with pulmonary involvement at age ≤18 years; (2) pulmonary function tests (PFTs) performed on patients after treatment completion; and (3) observational studies, including cohort and cross-sectional studies. We adhered to the recommendations of the Cochrane Collaboration and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Results: From 8040 records, 5 studies were included (involving n=567 children), with spirometry measures from 4 studies included in the meta-analyses. The effect sizes of childhood TB on forced expiratory volume in the first second and forced vital capacity z-scores were estimated to be -1.53 (95% CI -2.65, -0.41; p=0.007) and -1.93 (95% CI -3.35, -0.50; p=0.008), respectively. Discussion: The small number of included studies reflects this under-researched area, relative to the global burden of TB. Nevertheless, as childhood PTB impacts future lung function, PFTs (such as spirometry) should be considered a routine test when evaluating the long-term lung health of children beyond their completion of TB treatment. PROSPERO registration number CRD42021250172.
Rapid determination of paeoniflorin from Paeonia sinjiang K. Y. Pan. by rapid resolution liquid chromatography

Xiaoying Zhou,Xiao-ming Chen,Liang Ge,H. Gong,S. Tian,D. An

DOI: https://doi.org/10.4103/0973-1296.62893

2010-04-01

Pharmacognosy Magazine

Abstract:A rapid, effective, binary reverse phase rapid resolution liquid chromatographic method has been developed for the determination of Paeoniflorin extracted from Paeonia sinjiang K. Y. Pan. with short run time. RRLC separation was achieved by using Agilent (Zorbas XDB-C18 4.6 mm × 50 mm, 1.8 μm) column with mobile phase complosed of methanol and 0.05 mol/l potassium phosphate monobasic. Flow rate was at 1.0 ml/min. Retention time was at about 1.16 min. Recovery rate was 99.8% and relative standard deviation of three replicate samples tested was 1.8%. RRLC method has been applied to both in vitro studies of paeoniflorin formulation and drug estimation in biological samples.
Treatment of schizophrenia and delusional disorder in the elderly

J. Eastham,D. Jeste

DOI: https://doi.org/10.1007/BF02900217

European Archives of Psychiatry and Clinical Neuroscience

Abstract:
Thermoperiods and Production of Apothecial Initials in the Fungus Sclerotinia trifoliorum.

T. Sproston,D. Pease

DOI: https://doi.org/10.1126/SCIENCE.125.3248.599

IF: 56.9

1957-03-29

Science

Abstract:
Treatment Outcomes of Childhood Tuberculosis in Three Districts of Balochistan, Pakistan: Findings from a Retrospective Cohort Study

Abid Abdullah,Nafees Ahmad,Muhammad Atif,Shereen Khan,Abdul Wahid,Izaz Ahmad,Asad Khan

DOI: https://doi.org/10.1093/tropej/fmaa042

2020-07-10

Journal of Tropical Pediatrics

Abstract:Abstract Background This study aimed to evaluate treatment outcomes and factors associated unsuccessful outcomes among pediatric tuberculosis (TB) patients (age ≤14 years). Methods This was a retrospective cohort study conducted at three districts (Quetta, Zhob and Killa Abdullah) of Balochistan, Pakistan. All childhood TB patients enrolled for treatment at Bolan Medical Complex Hospital (BMCH) Quetta and District Headquarter Hospitals of Zhob and Killa Abdullah from 1 January 2016 to 31 December 2018 were included in the study and followed until their treatment outcomes were reported. Data were collected through a purpose developed standardized data collection form and analyzed by using SPSS 20. A p-value <0.05 was considered statistically significant. Results Out of 5152 TB patients enrolled at the study sites, 2184 (42.4%) were children. Among them, 1941 childhood TB patients had complete medical record were included in the study. Majority of the study participants were <5 years old (66.6%) and had pulmonary TB (PTB; 65%). A total of 45 (2.3%) patients were cured, 1680 (86.6%) completed treatment, 195 (10%) lost to follow-up, 15 (0.8%) died, 5 (0.3%) failed treatment and 1 (0.1%) was not evaluated for outcomes. In multivariate binary logistic regression analysis, treatment at BMCH Quetta (OR = 25.671, p-value < 0.001), rural residence (OR = 3.126, p-value < 0.001) and extra-PTB (OR = 1.619, p-value = 0.004) emerged as risk factors for unsuccessful outcomes. Conclusion The study sites collectively reached the World Health Organization’s target of treatment success (>85%). Lost to follow-up was the major reason for unsuccessful outcomes. Special attention to patients with identified risk factors for unsuccessful outcomes may improve outcomes further.

pediatrics,tropical medicine
Childhood tuberculosis outcomes and factors associated with unsuccessful treatment outcomes in selected public hospitals of Lusaka Zambia from 2015 to 2019

Dennis Ngosa,Joseph Lupenga

DOI: https://doi.org/10.1371/journal.pgph.0002591

2024-10-11

Abstract:Treatment outcomes of tuberculosis in children are rarely evaluated. Childhood tuberculosis has been a low priority for tuberculosis programs due to difficulties in diagnosis and treatment. This study evaluated childhood tuberculosis outcomes and factors associated with unsuccessful treatment outcomes in selected public hospitals in Lusaka, Zambia from 2015 to 2019. This was a cross-sectional study conducted in eight public hospitals in Lusaka. All children aged 0-14 years, treated with tuberculosis and had treatment outcomes evaluated were included. The WHO tuberculosis treatment outcomes were grouped into successful treatment outcome (cured, treatment completed) and unsuccessful treatment outcome (death, loss to follow-up, failure). Taking unsuccessful treatment outcome as the outcome variable, logistic regression models were performed. All analyses were done at a 95% confidence interval. Out of 2,531 children managed for TB from 2015 to 2019, only 1,495 (59.1%) had treatment outcomes evaluated. Out of 1,495 participants, majority were 5 to 14 years old (50.9%), males (51.1%), HIV-negative (58.7%), and had pulmonary tuberculosis (74.2%). Bacteriological tests were performed on 59.8% of children, where 21.6% had positive bacteriological results. Bacteriologically confirmed TB was higher in children over 5 years (29.5%), pulmonary TB (25.6%), and retreatment (28.6%). The majority of children (84.2%) completed treatment, while 10.7% were cured, 1.5% were lost to follow-up, 3.1% died, and 0.5% failed treatment. Overall, unsuccessful treatment outcome was 5.1% while successful treatment outcome was 94.1%. Extrapulmonary tuberculosis was associated with unsuccessful treatment outcomes (AOR 1.64; 95% CI: 1.02-2.62). The tuberculosis successful treatment outcome met the World Health Organization's threshold goal of 90%. Children with extrapulmonary tuberculosis should be targeted as a high-risk group to improve treatment outcomes. Tracking children whose treatment outcomes were not evaluated would provide more precise estimates of TB treatment outcomes.
Missed opportunities in the prevention and diagnosis of pediatric tuberculosis: a scoping review

Daniela Otoni Russo,Ana Luisa Lodi Jimenez,Lilian Martins Oliveira Diniz,Claudete Araújo Cardoso,Roberta Maia de Castro Romanelli

DOI: https://doi.org/10.1016/j.jped.2023.10.009

IF: 2.99

2024-01-01

Jornal de Pediatria

Abstract:OBJECTIVES: Identify potential barriers, delays, and missed opportunities in the prevention and diagnosis of childhood TB.METHODS: Scoping review according to the PRISMA extension. The definitions considered for the selection followed the acronym PCC where the population (P) is children under 18 years of age with TB disease, the concept (C) refers to missed opportunities for prevention and diagnosis, and context (C) is defined as a diagnosis of TB disease. The authors searched systematically in the databases; VHL/Lilacs, Medline via PubMed, Cochrane, Scopus, and Web of Science, without date or language limitation.RESULTS: Seven studies were included. In developed countries, with low disease burden, the main shortcoming is the delay in diagnosing bacilliferous adults in contact with young children. This problem is concentrated in the portion of the population with socioeconomic vulnerability. In underdeveloped countries, with a high burden of disease, the biggest challenge is tracking children who come into contact with bacilliferous patients.CONCLUSIONS: There are still many missed opportunities in the prevention and diagnosis of childhood TB. The positive legacy of the COVID-19 pandemic should be taken advantage of and the encouragement of scientific development in the management of infectious diseases should be taken.

pediatrics
The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis

Leonardo Martinez,Olivia Cords,C Robert Horsburgh,Jason R Andrews,Pediatric TB Contact Studies Consortium,Carlos Acuna-Villaorduna,Shama Desai Ahuja,Neus Altet,Orvalho Augusto,Davit Baliashvili,Sanjay Basu,Mercedes Becerra,Maryline Bonnet,W Henry Boom,Martien Borgdorff,Fadila Boulahbal,Anna Cristina C Carvalho,Joan A Cayla,Tsira Chakhaia,Pei-Chun Chan,Ted Cohen,Julio Croda,Sumona Datta,Helena Del Corral,Justin T Denholm,Reynaldo Dietze,Claudia C Dobler,Simon Donkor,Uzochukwu Egere,Jerrold J Ellner,Marcos Espinal,Carlton A Evans,Chi-Tai Fang,Katherine Fielding,Greg J Fox,Luis F García,Alberto L García-Basteiro,Steffen Geis,Stephen M Graham,Louis Grandjean,Djohar Hannoun,Mark Hatherill,Anja M Hauri,Anneke C Hesseling,Philip C Hill,Li-Min Huang,Helena Huerga,Rabia Hussain,Leah Jarlsberg,Edward C Jones-López,Seiya Kato,Midori Kato-Maeda,Beate Kampmann,H Lester Kirchner,Afrânio Kritski,Christoph Lange,Chih-Hsin Lee,Li-Na Lee,Meng-Rui Lee,Antonio Carlos Lemos,Christian Lienhardt,Du-Lin Ling,Qiao Liu,Nathan C Lo,Richard Long,Elisa Lopez-Varela,Peng Lu,Matthew Magee,LaShaunda L Malone,Anna M Mandalakas,Neil A Martinson,Rufaida Mazahir,Megan B Murray,Eduardo Martins Netto,Larissa Otero,Julie Parsonnet,Arthur Reingold,H Simon Schaaf,James A Seddon,Surendra Sharma,Jitendra Singh,Sarman Singh,Rosa Sloot,Giovanni Sotgiu,Catherine M Stein,Najeeha Talat Iqbal,Rina Triasih,Lisa Trieu,Maarten F Schim van der Loeff,Patrick Van der Stuyft,Cari van Schalkwyk,Richa Vashishtha,Lilly M Verhagen,Julian A Villalba,Jann-Yuan Wang,Christopher C Whalen,Takashi Yoshiyama,Heather J Zar,Jean-Pierre Zellweger,Limei Zhu

DOI: https://doi.org/10.1016/S0140-6736(20)30166-5

2020-03-21

Abstract:Background: Tens of millions of children are exposed to Mycobacterium tuberculosis globally every year; however, there are no contemporary estimates of the risk of developing tuberculosis in exposed children. The effectiveness of contact investigations and preventive therapy remains poorly understood. Methods: In this systematic review and meta-analysis, we investigated the development of tuberculosis in children closely exposed to a tuberculosis case and followed for incident disease. We restricted our search to cohort studies published between Jan 1, 1998, and April 6, 2018, in MEDLINE, Web of Science, BIOSIS, and Embase electronic databases. Individual-participant data and a pre-specified list of variables were requested from authors of all eligible studies. These included characteristics of the exposed child, the index case, and environmental characteristics. To be eligible for inclusion in the final analysis, a dataset needed to include: (1) individuals below 19 years of age; (2) follow-up for tuberculosis for a minimum of 6 months; (3) individuals with household or close exposure to an individual with tuberculosis; (4) information on the age and sex of the child; and (5) start and end follow-up dates. Studies assessing incident tuberculosis but without dates or time of follow-up were excluded. Our analysis had two primary aims: (1) estimating the risk of developing tuberculosis by time-period of follow-up, demographics (age, region), and clinical attributes (HIV, tuberculosis infection status, previous tuberculosis); and (2) estimating the effectiveness of preventive therapy and BCG vaccination on the risk of developing tuberculosis. We estimated the odds of prevalent tuberculosis with mixed-effects logistic models and estimated adjusted hazard ratios (HRs) for incident tuberculosis with mixed-effects Poisson regression models. The effectiveness of preventive therapy against incident tuberculosis was estimated through propensity score matching. The study protocol is registered with PROSPERO (CRD42018087022). Findings: In total, study groups from 46 cohort studies in 34 countries-29 (63%) prospective studies and 17 (37%) retrospective-agreed to share their data and were included in the final analysis. 137 647 tuberculosis-exposed children were evaluated at baseline and 130 512 children were followed for 429 538 person-years, during which 1299 prevalent and 999 incident tuberculosis cases were diagnosed. Children not receiving preventive therapy with a positive result for tuberculosis infection had significantly higher 2-year cumulative tuberculosis incidence than children with a negative result for tuberculosis infection, and this incidence was greatest among children below 5 years of age (19·0% [95% CI 8·4-37·4]). The effectiveness of preventive therapy was 63% (adjusted HR 0·37 [95% CI 0·30-0·47]) among all exposed children, and 91% (adjusted HR 0·09 [0·05-0·15]) among those with a positive result for tuberculosis infection. Among all children <5 years of age who developed tuberculosis, 83% were diagnosed within 90 days of the baseline visit. Interpretation: The risk of developing tuberculosis among exposed infants and young children is very high. Most cases occurred within weeks of contact investigation initiation and might not be preventable through prophylaxis. This suggests that alternative strategies for prevention are needed, such as earlier initiation of preventive therapy through rapid diagnosis of adult cases or community-wide screening approaches. Funding: National Institutes of Health.
Risk factors for poor outcome in childhood tuberculous meningitis

Mao-Shui Wang,Mei Zhao,Xin-Jie Liu

DOI: https://doi.org/10.1038/s41598-021-87082-5

IF: 4.6

2021-04-21

Scientific Reports

Abstract:Abstract Tuberculous meningitis (TBM) remains a serious disease for children and its risk factors of poor outcome remain unclear. Therefore, a retrospective study was conducted aiming to investigate the risk factors associated with poor outcome of childhood TBM. Between January 2006 and December 2019, consecutive children patients (≤ 15 years old) who had a diagnosis of TBM were included for the analysis. The demographic, clinical, laboratory, and radiographic data were collected from the electronic medical records retrospectively. Poor outcome was defined as death or transfer to a higher-level hospital. Patients were then divided into good and poor outcome groups. Subsequently, risk factors for poor outcome were estimated using univariate and multivariate logistic regression analysis. A total of 149 children with TBM was enrolled, twenty-two patients suffered poor outcome, including 16 transfers to a higher-level hospital and 6 deaths, and the remaining 127 patients were classified as good outcome group. Further multivariate analysis revealed that coma (age- and sex-adjusted OR = 6.425, 95% CI: 1.743, 23.676; P 1188.3 mg/L; age- and sex-adjusted OR = 4.680, 95% CI: 1.469, 14.902; P < 0.01) were associated with the poor outcome of childhood TBM. Childhood TBM remains to have a high mortality rate in China. High CSF protein and coma were identified as risk factors for poor outcome of childhood TBM. Hence, more attention is required to be paid to suspected patients with such characteristics, thus facilitating access to optimum treatment.

multidisciplinary sciences
Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland

Eileen Sweeney,Darren Dahly,Nahed Seddiq,Gerard Corcoran,Mary Horgan,Corinna Sadlier

DOI: https://doi.org/10.1186/s12879-019-4026-z

2019-05-09

Abstract:Background: Tuberculosis (TB) is the ninth leading cause of death worldwide and the leading cause from a single infectious agent. Bacillus Calmette-Guerin (BCG) is the only licensed vaccine for TB, yet its efficacy remains debated with variations in vaccine sub-strains, policies, and practices observed across the world. Three BCG vaccination policies were implemented across adjoining regions in the South West of Ireland from 1972; neonatal vaccination (vaccinated Region-A), vaccination of children aged 10-12 years (vaccinated Region-B) and no vaccination (unvaccinated Region-C). The aim of this study is to examine the impact of different BCG vaccination policies on incidence of TB disease in the South of Ireland over a 13-year period. Methods: Cases of active TB disease from 2003 to 2016 were identified through surveillance data. Residential addresses for each case were geocoded using the Google Maps API. Addresses were linked to 2011 census population data and to Local Health Offices BCG coverage data for study regions A-C. A steady-state population was assumed to calculate the 13-year incidence of TB disease. Using SatScan (v9.4.4), spatial clusters were identified at a small area level with the spatial scan statistic based on the discrete Poisson probability distribution. Results: Of 621 TB disease cases identified, 510 could be linked to the study area based on the reported addresses. The median age was 42 years (range 4 months - 94 years), 65% male and 66% Irish born. The incidence of TB disease was higher in the unvaccinated population, region-C 132/100,000 (95% CI 116-150) versus vaccinated region-A 56/100,000 (95%CI 45-69) and region-B 44/100,000 (95%CI 29-63). A spatial cluster analysis identified a single high-risk cluster in region -C where the relative risk (vs. the areas outside of the cluster) was 4.94 (95% CI 4.03 to 5.96). Conclusion: Our study demonstrates significant regional variation in the incidence of TB in demographically similar populations based on BCG vaccination policy. This observation is particularly noteworthy in a country with low TB disease incidence such as Ireland. These findings strengthen existing data demonstrating efficacy of BCG vaccination for primary prevention of TB disease.
Global estimates of paediatric tuberculosis incidence in 2013-19: a mathematical modelling analysis

Sita Yerramsetti,Ted Cohen,Rifat Atun,Nicolas A Menzies

DOI: https://doi.org/10.1016/S2214-109X(21)00462-9

Abstract:Background: Many children who develop tuberculosis are thought to be missed by diagnostic and reporting systems. We aimed to estimate paediatric tuberculosis incidence and underreporting between 2013 and 2019 in countries representing more than 99% of the global tuberculosis burden. Methods: We developed a mathematical model of paediatric tuberculosis natural history, accounting for key mechanisms and risk factors for infectious exposure (HIV, malnutrition, and BCG non-vaccination), the probability of infection given exposure, and progression to disease among infected individuals. We extracted paediatric population estimates from UN Population Division data, and we used WHO estimates for adult tuberculosis incidence rates. We parameterised this model for 185 countries and calibrated it using data from countries with stronger case detection and reporting systems. Using this model, we estimated trends in paediatric incidence, and the proportion of these cases that are diagnosed and reported (case detection ratio [CDR]) for each country, age group, and year. Findings: For 2019, we estimated 997 500 (95% credible interval [CrI] 868 700-1 163 100) incident tuberculosis cases among children, with 481 000 cases (398 400-587 400) among those aged 0-4 years and 516 500 cases (442 900-608 000) among those aged 5-14 years. The paediatric CDR was estimated to be lower in children aged 0-4 years (41%, 95% CrI 34-50) than in those aged 5-14 years (63%, 53-75) and varied widely between countries. Estimated CDRs increased substantially over the study period, from 18% (15-20) in 2013 to 53% (45-60) in 2019, with improvements concentrated in the Eastern Mediterranean, South-East Asia, and Western Pacific regions. Over the study period, global incidence was estimated to have declined slowly at an average annual rate of 1·52% (1·42-1·66). Interpretation: Paediatric tuberculosis causes substantial morbidity and mortality, and these data indicate that cases (and, thus, probably associated mortality) are currently substantially underreported. These findings reinforce the need to ensure prompt diagnosis and care for children developing tuberculosis, strengthen reporting systems, and invest in research to develop more accurate and easy-to-use diagnostics for paediatric tuberculosis in high-burden settings. Funding: National Institutes of Health.
Mortality of children and adolescents co-infected with tuberculosis and HIV: a systematic review and meta-analysis

Fei-Hong Hu,Xiao-Lei Tang,Meng-Wei Ge,Yi-Jie Jia,Wan-Qing Zhang,Wen Tang,Lu-Ting Shen,Wei Du,Xiao-Peng Xia,Hong-Lin Chen

DOI: https://doi.org/10.1097/qad.0000000000003886

IF: 4.632

2024-03-18

AIDS

Abstract:Objective: Children and adolescents with HIV infection are well-known to face a heightened risk of tuberculosis. However, the exact mortality rates and temporal trends of those with HIV-TB co-infection remain unclear. We aimed to identify the overall mortality and temporal trends within this population. Methods: PubMed, Web of Science, and Embase were employed to search for publications reporting on the mortality rates of children and adolescents with HIV-TB co-infection from inception to March 2, 2024. The outcome is the mortality rate for children and adolescents with HIV-TB co-infection during the follow-up period. In addition, we evaluate the temporal trends of mortality. Results: During the follow-up period, the pooled mortality was 16% (95% CI 13–20). Single infection of either HIV or TB exhibit lower mortality rates (6% and 4%, respectively). We observed elevated mortality risks among individuals aged less than 12 months, those with EPTB, poor adherence to ART, and severe immunosuppression. In addition, we observed a decreasing trend in mortality before 2008 and an increasing trend after 2008, although the trends were not statistically significant (P = 0.08 and 0.2 respectively). Conclusions: Children and adolescents with HIV-TB co-infection bear a significant burden of mortality. Timely screening, effective treatment, and a comprehensive follow-up system contribute to reducing the mortality burden in this population.

immunology,infectious diseases,virology
Tuberculosis treatment loss to follow-up in children exposed at home: A prospective cohort study

Meredith B Brooks,Brittney J van de Water,Leonid Lecca,Chuan-Chin Huang,Letizia Trevisi,Carmen Contreras,Jerome T Galea,Roger Calderon,Rosa Yataco,Megan Murray,Mercedes C Becerra

DOI: https://doi.org/10.7189/jogh.14.04194

2024-08-16

Abstract:Background: Loss to follow-up (LTFU) from tuberculosis (TB) treatment and care is a significant public health problem. It is important to understand what drives LTFU in children - a population whose treatment and management depend on an adult caregiver - to better provide support services to families affected by TB. Methods: We conducted a prospective cohort study of household contacts in Lima, Peru (2009-12). Using multilevel logistic regression analysis, we explored individual-level characteristics of children and their adult household members with TB disease to identify risk factors for LTFU among children initiated on treatment for TB. Results: A total of 154 child (0-14 years) household contacts were diagnosed with TB and initiated on treatment. While most (n = 133, 86.4%) had a successful outcome, 20 (13.0%) children were LTFU. Six (30.0%) children were LTFU within three months, nine (45.0%) between five to seven months, and three (15.0%) after seven months of treatment being initiated. In univariable analysis, children with index patients above 25 years of age had decreased odds of being LTFU (odds ratio = 0.26; 95% confidence interval = 0.08-0.84) compared to children with index patients 25 years or younger. Conclusions: In this cohort, more than 10% of children sick with TB who were exposed to the disease at home were LTFU. An integrated, family-centred TB prevention and management approach may reduce barriers to a child completing their course of TB treatment.
Waterpipe Smoking And The DRD2/ANKK1 Genotype.

G. Radwan,C. Loffredo,M. E. El Setouhy,M. Abdel Hamid,E. Israel,M. Mohamed

Journal of Egyptian Public Health Association

Abstract:BACKGROUND Waterpipe smoking is increasingly a worldwide phenomenon. Few studies have been conducted on the epidemiology of waterpipe smoking behavior and its genetic determinants. A polymorphism (TaqI) in the 3' untranslated region of the dopamine receptor gene (DRD2), later localized to the neighboring ANKK1 gene, has been previously linked to cigarette smoking. Since all tobacco products share the ability of stimulating the dopaminergic reward system, variation in the DRD2 genotype might be associated with waterpipe smoking addiction. AIM This study aims to explore genetic variations in DRD2 gene and waterpipe smoking, motives and addiction in Egyptian rural males. MATERIAL AND METHODS The subjects (N=154) were selected from participants in a household smoking prevalence survey if they were adults, males, currently smoking waterpipe and not smoking cigarettes. Participants were interviewed about their smoking behaviors. Blood samples were genotyped by polymerase chain reaction (PCR). Subjects were subsequently classified as either the A1 (presence of at least one A1 allele) or A2 group (A2 homozygotes). RESULTS The prevalence of A1 genotype was 34.4 % in current waterpipe users, and was associated with the maximum duration before smokers experienced craving to smoke: after adjusting for age of smoking initiation, smoking for addictive motives, and average daily tobacco consumption, the A1 carriers were more likely to experience craving within a shorter duration after abstinence (the first 24 hours) compared to subjects with A2/A2 genotype (Odds ratio [OR] 2.70, 95% confidence interval [CI]: 1.18 - 6.23). In addition, the frequent visitors of shisha cafes were more likely to be younger, heavy smokers and carriers of A1 allele (OR, 2.52, 95% CI: 1.06-6.02). CONCLUSION AND RECOMMENDATIONS This study revealed that the maximum duration before experiencing craving to smoke waterpipe and frequency of visiting cafés to smoke may be influenced by an inherited variations in the DRD2 genotype.
Time to be seen and heard: Including children's and adolescents' voices in the South African TB response

C Goslett,K Du Preez,G Hendricks,A Best

DOI: https://doi.org/10.7196/SAMJ.2024.v114i17.2040

2024-07-01

Abstract:Ciara Goslett's account of childhood tuberculosis (TB) sheds light on the challenges faced by children diagnosed with TB in South Africa (SA). Children are particularly vulnerable to TB infection and to dangerous forms of disseminated TB such as TB meningitis, which can cause death or major lifelong disability. They have distinct challenges with diagnosis, and TB treatment for adults is not necessarily child- friendly. In the absence of a child-friendly formulation, adult tablets are broken into the correct dosage and used to treat children. Crushed and dissolved in water, the pieces are not very palatable for children. There are therefore issues that may be neglected if the voices of children are not included in the TB response in SA. These include delays in the development and accessibility of child-friendly medication, vaccine shortages and a lack of educational support for hospitalised children under school-going age. Some positive progress has been made through the establishment of the paediatric working group in the TB Think Tank, and SA's contribution to pivotal childhood TB research studies. Additional steps could be the inclusion of children's feedback in community-led monitoring efforts and engagement between child TB activists and the SA TB Caucus, a collective of parliamentarians.
A Review Of Host-Specific Diagnostic And Surrogate Biomarkers In Children With Pulmonary Tuberculosis

Junaid Shaik,Manormoney Pillay,Prakash Jeena

DOI: https://doi.org/10.1016/j.prrv.2024.01.005

IF: 5.526

2024-02-01

Paediatric Respiratory Reviews

Abstract:BACKGROUND: Tuberculosis (TB) is one of the most common causes of mortality globally with a steady rise in paediatric cases in the past decade. Laboratory methods of diagnosing TB and monitoring response to treatment have limitations. Current research focuses on interrogating host- and/or pathogen-specific biomarkers to address this problem.METHODS: We reviewed the literature on host-specific biomarkers in TB to determine their value in diagnosis and treatment response in TB infected and HIV/TB co-infected children on anti-tuberculosis treatment.RESULTS AND CONCLUSION: While no single host-specific biomarker has been identified for diagnosis or treatment responses in children, several studies suggest predictive biosignatures for disease activity. Alarmingly, current data on host-specific biomarkers for diagnosing and assessing anti-tuberculosis treatment in TB/HIV co-infected children is inadequate. Various factors affecting host-specific biomarker responses should be considered in interpreting findings and designing future studies within specific clinical settings.

pediatrics,respiratory system
Patterns And Outcomes In Pediatric Abdominal Tuberculosis: A Single Centre Cohort Study

Susan John,Dhruva Ghosh,Vishal Michael,Deirdre Kruger,Ritu Jain,Karan Dhir,Sangeetha Mohan,Aneel Bhangu

DOI: https://doi.org/10.1016/j.jpedsurg.2024.04.006

IF: 2.549

2024-04-24

Journal of Pediatric Surgery

Abstract:Introduction Abdominal tuberculosis presents in a variety of ways. Different testing modalities must be applied in addition to having a high clinical suspicion to diagnose and initiate therapy. Medications have a good response; however, morbidity has been seen following surgical management of complicated presentations like intestinal obstruction and perforation. There is a paucity of studies in the pediatric age group which evaluate response to the different treatment regimen and identify factors associated with poorer outcomes in children with abdominal tuberculosis. Methods Patient records of 75 children with abdominal tuberculosis at a single center were evaluated using a questionnaire, covering a 14-year period from 2007 to 2021. Demographic features, presenting signs and symptoms, investigations and treatment details were studied. In- person or telephonic follow-up was conducted to identify treatment outcomes. Results Incidence of abdominal TB was 7%, of all TB children with a mean age of 10.1 years. Mesenteric lymph nodes were involved in 67% and small intestine in 33% cases. Surgery was required in 22 children. 85% children completed treatment. Small intestine involvement had higher probability of undergoing surgery. Of the 70 children with complete follow up, 64 were well and 6 children succumbed to the disease. Older age, small intestine involvement and surgery were independently associated with higher mortality. Conclusion Intestinal involvement is associated with greater need for surgical intervention and greater mortality. Adolescents have poorer outcomes. Further studies are required focusing on these individual subgroups to understand the patterns of presentation, causes for mortality and prevention. Level Of Evidence Level 5

pediatrics,surgery

[The cholesterol controversy (author's transl)].

Retrospective cohort study exploring the impact of universal Tuberculosis (TB) vaccination cessation on the epidemiology of paediatric TB in Ireland, 2011–2021

Effectiveness of Bacillus Calmette–Guérin vaccination against severe childhood tuberculosis in China: a case-based, multicenter retrospective study

Diagnostic Accuracy of Clinical Diagnostic Scoring Systems for Childhood Tuberculosis: A Systematic Review and Meta-Analysis

Pulmonary function outcomes after tuberculosis treatment in children: a systematic review and meta-analysis

Rapid determination of paeoniflorin from Paeonia sinjiang K. Y. Pan. by rapid resolution liquid chromatography

Treatment of schizophrenia and delusional disorder in the elderly

Thermoperiods and Production of Apothecial Initials in the Fungus Sclerotinia trifoliorum.

Treatment Outcomes of Childhood Tuberculosis in Three Districts of Balochistan, Pakistan: Findings from a Retrospective Cohort Study

Childhood tuberculosis outcomes and factors associated with unsuccessful treatment outcomes in selected public hospitals of Lusaka Zambia from 2015 to 2019

Missed opportunities in the prevention and diagnosis of pediatric tuberculosis: a scoping review

The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis

Risk factors for poor outcome in childhood tuberculous meningitis

Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland

Global estimates of paediatric tuberculosis incidence in 2013-19: a mathematical modelling analysis

Mortality of children and adolescents co-infected with tuberculosis and HIV: a systematic review and meta-analysis

Tuberculosis treatment loss to follow-up in children exposed at home: A prospective cohort study

Waterpipe Smoking And The DRD2/ANKK1 Genotype.

Time to be seen and heard: Including children's and adolescents' voices in the South African TB response

A Review Of Host-Specific Diagnostic And Surrogate Biomarkers In Children With Pulmonary Tuberculosis

Patterns And Outcomes In Pediatric Abdominal Tuberculosis: A Single Centre Cohort Study